Vycor Medical, Inc.
VYCO
Rank in Stocks
#32496
Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and... Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access Systemโa critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.
Share Price
$0.044
Last synced: 2026-11-13
Market Cap
$1.47M
Change (1 day)
0.00%
Change (1 year)
-74.86%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Vycor Medical, Inc. (VYCO)
Category
Healthcare
Operating Margin for Vycor Medical, Inc. (VYCO)
Operating Margin as of November 2026 TTM: 2.55%
According to Vycor Medical, Inc.'s latest financial reports, its current operating margin (TTM) is 2.55%. At the end of 2025 the company had an operating margin of 1.82%.
Operating Margin history for Vycor Medical, Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.55% | 40.11% |
| 2025 | 1.82% | -413.79% |
| 2024 | -0.58% | -121.09% |
| 2023 | 2.75% | -110.97% |
| 2022 | -25.06% | -19.94% |
| 2021 | -31.30% | -50.45% |
| 2020 | -63.17% | 29.08% |
| 2019 | -48.94% | -43.95% |
| 2018 | -87.31% | -7.87% |
| 2017 | -94.77% | -13.49% |
| 2016 | -109.55% | -37.35% |
| 2015 | -174.86% | -19.98% |
| 2014 | -218.52% | 4.34% |
| 2013 | -209.43% | -9.66% |
| 2012 | -231.82% | -51.34% |
| 2011 | -476.41% | -1.63% |
| 2010 | -484.29% | 2.27% |
| 2009 | -473.56% | -58.17% |
| 2008 | -1,132.05% | -94.03% |
| 2007 | -18,960.16% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.00% | -94.12% |
US
|
|
| 18.08% | -92.91% |
IE
|
|
| 21.25% | -91.67% |
US
|
|
| 21.05% | -91.75% |
US
|
|
| 25.52% | -89.99% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Vycor Medical, Inc.'s operating margin
What is Vycor Medical, Inc.'s operating margin?
Vycor Medical, Inc.'s operating margin is 2.55%, as of Nov 2026.
What was Vycor Medical, Inc.'s operating margin in 2025?
In 2025, Vycor Medical, Inc.'s operating margin was 1.82%, compared with -0.58% in 2024.
How has Vycor Medical, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Vycor Medical, Inc.'s operating margin was highest in 2023 (2.75%) and lowest in 2020 (-63.17%).
How does Vycor Medical, Inc.'s operating margin compare with similar companies?
Vycor Medical, Inc.'s operating margin (2.55%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.